CL
Charles W Lynde

Elite Scholar

470
Works
15,485
Citations
65
H-Index
Search Authors
Author Statistics
External Links
OpenAlex Profile ORCID Profile

Charles W Lynde

Also known as: C LYNDE, C Lynde, C W Lynde, C. Lynde, C. W. Lynde

470

Total Works

15,485

Citations

65

H-Index

197

i10-Index

Citation & Works Trend by Year
34 years active
Top Research Topics
Dermatology and Skin Diseases (332) Psoriasis: Treatment and Pathogenesis (244) Spondyloarthritis Studies and Treatments (141) Asthma and respiratory diseases (72) Contact Dermatitis and Allergies (62)
Recent Publications
15 shown
Year Publication Title Citations Action
2026 Canadian Expert Consensus Recommendations on the Use of Photodynamic Therapy in Actinic Keratosis Dermatology and Therapy 0
2026 Vitiligo Biomarker CXCL10 Correlates With Clinical Response to Ruxolitinib Cream in the Phase 2 Randomized TRuE-V Mechanism-of-Action Study Journal of Investigative Dermatology 0
2026 Real-World Evidence of Upadacitinib in Atopic Dermatitis After Inadequate Response or Intolerance to Dupilumab: The CAN UpTIMISE Study Figshare 0
2026 Real-World Evidence of Upadacitinib in Atopic Dermatitis after Inadequate Response or Intolerance to Dupilumab: The CAN UpTIMISE Study Dermatology and Therapy 0
2026 Keeping It Real: Real-World Brodalumab Outcomes in the Context of Pivotal Trials for Moderate-to-Severe Plaque Psoriasis SKIN The Journal of Cutaneous Medicine 0
2026 CASMO RECOMMENDATIONS FOR PREVENTION AND TREATMENT OF CUTANEOUS ADVERSE EVENTS RELATED TO CANCER THERAPIES IN DARKER SKIN PHOTOTYPES Radiotherapy and Oncology 0
2026 Upadacitinib for Severe Alopecia Areata in Adults and Adolescents JAMA Dermatology 1
2026 Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study The Lancet 3
2026 Longitudinal Performance of the Psoriasis Epidemiology Screening Tool (PEST) in Canada and Latin America: Results from the Prospective, Observational, 5-Year PURE Registry Dermatology and Therapy 0
2026 A consensus-based treatment algorithm for alopecia areata in adolescents and adults: integrating severity, quality of life, and disease dynamics Frontiers in Medicine 1
2026 Long-term remission of severe psoriasis following CD19-directed chimeric antigen receptor T-cell therapy for follicular lymphoma Clinical and Experimental Dermatology 1
2026 Pushing the Boundaries of Topical Therapy in Patients with Atopic Dermatitis: A Review of Baseline Disease Severity and Burden in Clinical Trials Dermatology and Therapy 0
2026 72740 Real-World Effectiveness of Upadacitinib for Atopic Dermatitis Across Body Regions by Prior Biologic Exposure in the AD-VISE Study Journal of the American Academy of Dermatology 0
2026 76957 Efficacy and Safety of Upadacitinib in Adolescents and Adults with Severe Alopecia Areata: A Subgroup Analysis of the UP-AA Phase 3 Clinical Program Journal of the American Academy of Dermatology 0
2026 72990 CaSMO recommendations for prevention and treatment of cutaneous adverse events related to cancer therapies in darker skin phototypes Journal of the American Academy of Dermatology 0

Data source: OpenAlex API